To expand maternal-foetal health services in Eastern India
Suraksha Diagnostics has acquired a majority stake in Fetomat Wellness. Fetomat has foetal and maternal medicine centres in Eastern India for pregnancy care, prenatal diagnosis, and genetic counselling.
The strategic acquisition merges advanced diagnostics with specialised prenatal care enabling Suraksha Diagnostics to incorporate the specialised maternal-foetal services of Fetomat into its extensive diagnostic network. This in turn enhances the continuum of care for expectant mothers. The partnership will help in the early detection and management of fetal anomalies, high-risk pregnancies and other prenatal conditions, ensuring better health outcomes for both the mothers and their babies. The association enables the association of foetal medicine with genomics for the first time in Eastern India. This brings leading-edge genomic technology to be available for patients here. Patients will benefit from the streamlined access to advanced diagnostics and specialised prenatal care, making certain timely interventions and better health outcomes.
Dr Somnath Chatterjee, CMD, Suraksha Diagnostics, stated, “Acquiring a majority stake in Fetomat Wellness aligns with our vision to provide comprehensive healthcare solutions. This strategic move enhances our capabilities in maternal-foetal medicine, allowing us to offer integrated services that cater to the evolving needs of our patients.”
Dr Pradip Goswami, Founder and Director, Fetomat Wellness shared, “Joining forces with Suraksha Diagnostics marks a significant milestone for Fetomat. This partnership will amplify our reach and resources, enabling us to deliver specialised prenatal care to a broader patient base.”
